Navigation Links
Bayer CropScience Provides a Glimpse of SeedGrowth™ Innovation
Date:12/5/2012

Research Triangle Park, NC (PRWEB) December 05, 2012

Soybean growers in the Midwest continue to struggle with sudden death syndrome (SDS), which was discovered in 1971. According to the Plant Heatlh Initiative, SDS is now considered one of the top four yield-robbing diseases in soybean and appears to be spreading. The disease is capable of devastating soybean fields, affecting some growers’ entire soybean crops and significantly reducing their yield even up to 90 percent in some years.

Bayer CropScience SeedGrowth™ (formerly Seed Treatment) is studying a product it believes will combat SDS and give growers a much-needed solution to this problem. This new product is a seed treatment that is applied directly to soybean seed and helps to control the Fusarium fungus that causes SDS.

“Sudden death syndrome often doesn’t show symptoms in the soybeans until it is too late for the grower to help their crop,” said Ethan Luth, SeedGrowth product manager at Bayer CropScience, “We know growers are frustrated with SDS, and until now, there hasn’t been a complete solution. However, trials of our new product are showing promising results, and we believe it will help growers to prevent losses from SDS.”

The fungal pathogen that causes SDS favors cool, moist growing conditions for infection. During soybeans’ early development stages, the infection invades the root system, but there are no visible symptoms until after flowering, at which time there are no known treatment options. The fungal infection suddenly becomes obvious as leaves display intervenial yellowing and necrosis, resulting in leaf drop during the critical stage of pod filling and effecting yield potential.

“When managing Sudden Death Syndrome, it is important to utilize an
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
2. Bayer Bee Care Center Helps Solve Bee Health’s Toughest Challenges
3. Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
4. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
5. Bayer Advanced(TM) Sets Sights on New Partnerships in 2013
6. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
7. Organovo Reports Q3 2012 Financial Results, Provides Business Update
8. Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012
10. Anthera Pharmaceuticals Reports 2012 Third Quarter Financial Results And Provides Clinical Progress Update
11. Life Technologies New State-of-the-Art Manufacturing Facility in China Provides Forensics Labs Rapid Access to World-Leading DNA Testing Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013 ... of regenerative medicine, presented new data generated in collaboration ... (a leading health economics consultancy) demonstrating the significant healthcare ... and venous leg ulcers (VLU) place upon the US ... research, which reveal annual costs of up to $15 ...
(Date:5/22/2013)... 2013 Express Diagnostics Int’l, Inc. ... are pleased to announce a sponsorship agreement with ... New Zealand distributor of DrugCheck® onsite testing devices, manufactured ... in the Austin 400 May 17-19 in Austin, Texas. ... that involves each car of the Erebus Motorsport team ...
(Date:5/22/2013)... 22, 2013  Moderna Therapeutics, the pioneering company developing ... enable the in vivo production of therapeutic ... will join Moderna in early July as its ... a proven leader in the design and implementation of ... discovery to translation, clinical operations and commercial preparedness. John ...
(Date:5/21/2013)... Through science fairs, workshops, kits for ... equipment, 25 organizations will continue their work to increase ... photonics in daily life with the aid of ... in 10 countries, are the first of two groups ... SPIE, the international society for optics and photonics , ...
Breaking Biology Technology:Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3
... ChanTest, the leading expert in ion channels and ... development, and safety -- is one of eight organizations ... and Commercialization Program. Governor Ted Strickland and Interim Director ... the Ohio Third Frontier Commission, Mark Barbash, announced the ...
... Aegera Therapeutics is pleased to announce the initiation ... AEG33773, a novel, orally bio-available small molecule therapeutic ... , The Phase 2a study, entitled A Multicenter, ... Efficacy of AEG33773 versus Placebo in Patients with ...
... May 6 iZumi Bio, Inc., a biotechnology ... stem cell (iPS) technology with the mission of ... differentiation of patient cells, today announced the appointments ... (CTO) and Dushyant Pathak, Ph.D., as vice president ...
Cached Biology Technology:ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 3Aegera Initiates Phase 2 Clinical Trial Of AEG33773 - A Small Molecule Targeting Neuropathic Pain 2iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 2iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development 3
(Date:5/21/2013)... of Michigan Water Center today awarded 12 research ... restoration and protection efforts. , The two-year grants ... including efforts to track the remediation of harmful ... control non-native weedy plant invasions; study chromosomal damage ... to restoration activities. , The grants were awarded ...
(Date:5/21/2013)... decades, scientists have developed many devices that can reopen ... generally effective, each of these treatments has drawbacks, including ... from MIT analyzes the potential usefulness of a new ... drug-releasing stents, but may pose fewer risks. With this ... for only a brief period, during which it releases ...
(Date:5/20/2013)... also commonly resistant to antimicrobial substances made by ... mBio , the online open-access journal of ... and host antimicrobials LL-37 and lysozyme, which help ... that patients with life-threatening multi-drug resistant infections are ... is a last-line drug for treating several kinds ...
Breaking Biology News(10 mins):U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... It,s commonly known, at least among microbiologists, that ... dormancy. Dormant microbes are less like zombies ... is how large numbers of dormant microorganisms affect the ... In the current issue of Nature Reviews: Microbiology ...
... common connective tissue cell in animals is the fibroblast, which ... Neta Erez of Tel Aviv University,s Sackler Faculty of Medicine ... great harm, helping to "recruit" immune cells for tumor growth. ... cancer cell proliferation is beginning, fibroblasts rush to the scene ...
... have developed a novel system for delivery of growth ... diabetic foot ulcers. In their work published in ... of Sciences , the team from the MGH Center ... keratinocyte growth factor (KGF), a protein known to play ...
Cached Biology News:The undead may influence biodiversity, greenhouse gas emissions 2Infiltrating cancer's recruitment center 2Growth-factor-containing nanoparticles accelerate healing of chronic wounds 2
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGF1α by GC- or LC-mass spectrometry....
PGD2-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGD2 by GC- or LC-mass spectrometry....
Request Info...
Biology Products: